Abstract:Long noncoding RNAs (lncRNAs) have been reported to be involved in the occurrence and tumorigenesis of numerous malignant cancers. Microarray expression profiles were used to screen colorectal cancer (CRC)-related differentially expressed genes and lncRNAs, which revealed that insulin receptor substrate 1 (IRS1) and lncRNA plasmacytoma variant translocation 1 (PVT1) were highly expressed in CRC. This study aimed to investigate the regulatory role of lncRNA PVT1 in CRC. Subcellular localization detected by fluorescence in situ hybridization identified that lncRNA PVT1 was primarily located in the cytoplasm. The interaction between lncRNA PVT1 and microRNA-214-3p (miR-214-3p) and IRS1 was predicted using the RNA22 website. Next the dual luciferase reporter gene assay, RNA pull-down, and RNA immunoprecipitation assays verified lncRNA PVT1 to be a competitive endogenous RNA (ceRNA) against miR-214-3p. and IRS1 was found to be a target of miR-214-3p. The expression pattern of lncRNA PVT1, miR-214-3p, IRS1, phosphoinositide 3-kinase (PI3K), and Akt was characterized in response to lncRNA PVT1 silencing or miR-214-3p upregulation. Meanwhile, their regulatory effects on cell proliferation, invasion, and apoptosis were detected in CRC cells. With increased levels of miR-214-3p and decreased levels of lncRNA PVT1 in CRC cells, the expression of phosphatidylinositol 3-kinase. putative (PI3K) and Akt was reduced, and consequently, the cell apoptosis was stimulated and cell proliferation and invasion were suppressed. All in all, lncRNA PVT1 competitively binds to miR-214-3p to upregulate the expression of IRS1 thus activating the PI3K/Akt signaling pathway, thus accelerating CRC progression. This study suggests that lncRNA PVT1 might be a potential target of therapeutic strategies for CRC treatment. NEW & NOTEWORTHY This study mainly suggests that long noncoding (inc)RNA plasmacytoma variant translocation 1 (PVT1) is a downregulated lncRNA in colorectal cancer (CRC), accelerating CRC progression. Strikingly, lncRNA PVT1 acts as a competitive endogenous RNA against microRNA (miR)-214-3p. whereas miR-214-3p targets insulin receptor substrate 1, which draws a comprehensive picture of the potential molecular mechanisms of lncRNA PVT1 in CRC.

Long non-coding RNA PVT1 regulates the proliferationand metastasis of human breast cancer via theWnt/b-catenin signalling pathway

Long Non‑coding RNA PVT1 Promotes Epithelial‑mesenchymal Transition Via the TGF‑β/Smad Pathway in Pancreatic Cancer Cells.

Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1

LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p

Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.

Long Noncoding RNA PVT1 Indicates a Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation Through Epigenetically Regulating P15 and P16

Lncrna PVT1 Promotes Metastasis of Non-Small Cell Lung Cancer Through EZH2-Mediated Activation of Hippo/NOTCH1 Signaling Pathways

Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer

LncRNA PVT1 Regulates Mir-1207-5p to Affect Colon Cancer Proliferation and Migration Via the Wnt6/β-catenin2 Pathway.

LncRNA PVT1: a Novel Therapeutic Target for Cancers.

Effect of Long Non-Coding RNA PVT1 on Cell Proliferation and Migration in Melanoma

Lncrna PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing Mir-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis

LncRNA PVT1 Facilitates Proliferation, Migration and Invasion of NSCLC Cells via miR-551b/FGFR1 Axis

Long Non-Coding RNA PVT1-5 Promotes Cell Proliferation by Regulating Mir-126/Slc7a5 Axis in Lung Cancer

Lncrna PVT1 Identified As an Independent Biomarker for Prognosis Surveillance of Solid Tumors Based on Transcriptome Data and Meta-Analysis

&Lt;p>long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression Via Targeting Tumor Suppressor MicroRNAs</p>

lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression.

Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.

Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR)

The Long Noncoding RNA PVT1 Functions As a Competing Endogenous RNA by Sponging Mir-186 in Gastric Cancer.

Correction For: LncRNA PVT1 Accelerates Malignant Phenotypes of Bladder Cancer Cells by Modulating Mir-194-5p/bclaf1 Axis As a Cerna